Dose Response of Intravenous Sincalide(CCK-8) for Gallbladder Emptying
Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
This is a clinical research study to establish normal values for the infusion of a synthetic
form of the hormone cholecystokinin(CCK-8) for gallbladder emptying. Cholecystokinin is
released from the small bowel to stimulate the pancreas and gallbladder to help digest and
absorb food. Some people have gallbladder problems and need to be tested with the synthetic
cholecystokinin ( Kinevac®, Bracco Diagnostics, Inc.). The aim of this study is to find out
how differing amounts and intravenous infusion times of CCK-8 affect gallbladder emptying.
The findings in normal subjects will be used to establish normal values that can then be
compared with patients with suspected gallbladder disease.
Phase:
N/A
Details
Lead Sponsor:
Temple University
Collaborators:
Johns Hopkins University Memorial Health University Medical Center Penn State University